By contrast, neutralization of cfDNA after stroke by therapeutic administration of recombinant DNase following stroke induction again significantly reduced the plaque inflammasome activation, as measured by caspase-1 cleavage and IL-1β secretion (Fig. 2m,n and Extended Data Fig. 7e). The gene discussed is CASP1; the disease is stroke disorder.